Financials

News Discussions Technicals

IDXG fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Interpace Biosciences, Inc.

Total assets of IDXG for Q2 24 is 12.97 M USD, 6.84% more than the previous Q1 24. And total liabilities decreased by 4.80% in Q2 24 to 25.46 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—